SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests begin for experimental cancer drug targeting multiple tumor types
Disease control OngoingThis early-stage study is testing a new drug called PF-08046052/SGN-EGFRd2 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find the safest dose and understand side effects in 65 participants with specific cancers includin…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for Tough-to-Treat head and neck cancer
Disease control OngoingThis study is for people with advanced head and neck cancer that has returned or spread and has stopped responding to standard treatments. It tests whether adding an experimental drug called monalizumab to an existing cancer drug (cetuximab) helps patients live longer and better …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New drug strategy aims to stop aggressive head & neck cancer from coming back
Disease control OngoingThis study is testing if a drug called pembrolizumab can help people with recurrent head and neck cancer stay cancer-free for longer after a second surgery. The drug is an immunotherapy designed to help the body's own immune system fight the cancer. Researchers will give the drug…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Assuntina G. Sacco, MD • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New drug tested to stop aggressive head and neck Cancer's return
Disease control OngoingThis study is testing whether a drug called pembrolizumab can help prevent cancer from returning in people with high-risk head and neck cancer who have already finished their main treatment. About 100 patients will receive either the drug or a placebo for one year to see if it im…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New cancer drug shows promise in early human trials
Disease control OngoingThis early-stage trial is testing a new antibody drug called acasunlimab (GEN1046) for people with advanced solid tumors. The study first aims to find safe doses, then tests how well those doses work when given alone or combined with other cancer drugs. All 429 participants will …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Scientists map Cancer's secrets in blood and tumors
Knowledge-focused OngoingThis study aims to understand how certain advanced cancers change during treatment. Researchers will collect blood and tumor samples from 39 patients with specific types of recurrent or metastatic squamous cell cancers (head/neck, esophagus, anal canal) who are starting chemother…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC